Biotechnology

Flexion Therapeutics

$12.37
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.01 (+0.08%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell FLXN and other stocks, options, and ETFs commission-free!

About FLXN

Flexion Therapeutics, Inc. operates as a biopharmaceutical company, which engages in the development and commercialization of novel and local therapies. It specializes in the treatment of patients with musculoskeletal conditions including osteoarthritis. It offers products under the Zilretta brand. The company was founded by Michael D. Clayman and Neil Bodick on November 5, 2007 and is headquartered in Burlington, MA. The listed name for FLXN is Flexion Therapeutics, Inc. Common Stock.

CEO
Michael D. Clayman
Employees
288
Headquarters
Burlington, Massachusetts
Founded
2015
Market Cap
569.63M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
744.70K
High Today
$13.19
Low Today
$11.80
Open Price
$11.95
Volume
1.16M
52 Week High
$18.87
52 Week Low
$5.01

Collections

FLXN Earnings

-$1.05
-$0.70
-$0.35
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 11, After Hours

You May Also Like

WUGI
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure